Atomoxetine is a medication that is used to treat attention deficit hyperactivity disorder (ADHD). It belongs to a class of medications called selective norepinephrine reuptake inhibitors (SNRIs). The drug is sold under various brand names, including Strattera, Adderall, and Concerta.
This article describes the uses, side effects, and drug interactions of this medication. You can also read about other side effects of Strattera, such as dizziness, nausea, and insomnia.
Brand Name:Atomoxetine
Generic Name:Strattera
Brand Names:Strattera, Adderall, Adderall XR
Side Effects:Headache, dizziness, nausea, drowsiness, and sleepiness.
Drug Interactions:The most serious side effects of atomoxetine include:
Warnings and Precautions:This medication should not be taken by anyone under 18 years of age.
How to use:Use this medication only as directed. Do not exceed the recommended dose or duration of treatment. Do not use it for longer than recommended without medical supervision. For more information, ask your health care provider or pharmacist.
Important Note:
The typical starting dose for treating ADHD is a stimulant such as atomoxetine. The dose may be increased in increments of 2 mg per day.
The usual dosage for adults and adolescents 12 years and older is 40-80 mg daily.
Strattera may be taken with or without food, but a higher dose should be used when needed. Your doctor will determine the right dosage for you and may adjust your dose gradually.
Your doctor may start you at a low dose and gradually increase your dose to find the optimal dose for treating ADHD. If needed, your doctor may adjust your dose gradually. They may increase your dose slowly or increase your dose slowly.
Your doctor may also prescribe an alpha-2 agonist for atomoxetine, a drug that is used to treat ADHD. The alpha-2 agonist may be prescribed for adults and adolescents 12 years and older, or adults with ADHD, and children 12 years and older. The alpha-2 agonist may be prescribed for adults with ADHD or children 12 years and older.
For ADHD, atomoxetine is approved to treat attention deficit hyperactivity disorder (ADHD). It may also be prescribed for other conditions that may affect ADHD:
This medication can be prescribed by your doctor, including your primary care doctor.
For more information, ask your doctor or pharmacist.
Some people taking atomoxetine experience side effects. These side effects may be mild and may go away after a few days. The most common side effects include:
If you experience severe side effects, call your doctor immediately. They may want to check in with you to make sure the medication is working as it should. Your doctor will do lab tests and X-rays to check for any problems.
Strattera is a non-stimulant medication used to treat Attention Deficit Hyperactivity Disorder (ADHD). Strattera has been used for more than 20 years. It works by increasing the levels of certain chemicals in the brain.
Atomoxetine, the first-generation selective norepinephrine reuptake inhibitor (SNRI), was approved by the Food and Drug Administration (FDA) in 1997 as a treatment for ADHD in adults. It was approved by the FDA in 2002 and has since become the first non-stimulant to treat ADHD. Strattera has been available since 2010, with Strattera being the first non-stimulant approved to treat ADHD. Strattera is a generic medicine manufactured by Lilly and is marketed by Eli Lilly. Strattera is available in 30 mg and 60 mg dosage strengths. The recommended dosage for atomoxetine is 60 mg. The FDA approved Strattera in 2002 for treating ADHD in adults. The dosage may be increased from 30 mg to 60 mg, or reduced to 2 mg in a once-daily or once-weekly dosage. Strattera is not approved for use in children, adolescents, or adults. It is not known whether atomoxetine is approved for use in children, adolescents, or adults. The drug is not expected to have any negative side effects, including suicidal thoughts and behaviors. Strattera has not been approved for use in children and adolescents.
Strattera is an ADHD treatment that is primarily used for the treatment of Attention Deficit Hyperactivity Disorder (ADHD). It can be used for the treatment of ADHD and may be used alone or with other medication, or may be used in combination with other ADHD medications. Strattera has been approved for the treatment of ADHD in adults. It is approved to treat Attention Deficit Hyperactivity Disorder, a disorder that affects nearly 3.5 million adults in the United States. It is approved for the treatment of ADHD in children, adolescents, and adults. It is approved to treat ADHD in children and adolescents, or adults with attention problems and hyperactivity in adults. Strattera is not expected to have any negative side effects.Strattera is an ADHD treatment that is primarily used for the treatment of ADHD and may be used alone or with other medication, or may be used in combination with other ADHD medications. Strattera is approved for the treatment of ADHD in adults.Atomoxetine is a selective norepinephrine reuptake inhibitor (SNRI). It works by increasing the levels of certain chemicals in the brain, such as norepinephrine, dopamine, and serotonin, which are responsible for the regulation of attention, behavior, and impulse control. Strattera has been used for the treatment of Attention Deficit Hyperactivity Disorder (ADHD). It is approved for the treatment of ADHD in children and adolescents, or adults with attention problems and hyperactivity in adults. Strattera has not been approved for use in children and adolescents, or adults, with hyperactivity in adults.
Strattera is a non-stimulant medication that is used for the treatment of ADHD. It is approved to treat ADHD in adults. It is approved to treat ADHD in children, or adults with attention problems and hyperactivity in adults. It is approved to treat ADHD in children and adolescents.
Strattera may be used for the treatment of ADHD.
Atomoxetine may also be used to treat narcolepsy. It is approved to treat narcolepsy and narcolepsy sleep disorders. Strattera has been approved to treat narcolepsy and narcolepsy sleep disorders. Strattera has been approved to treat ADHD in adults.
Strattera note: As of November 2023, drug manufacturer Eli Lilly and Company discontinued all strengths of Strattera from the marketplace. Strattera generic, atomoxetine, is available.
| Abuse Potential | How to Use Strattera | Dosage |
|---|---|---|
| Acemetas (Strattera) | Prescription | 1 mg/ tablet |
| Atomoxetine (Strattera) | ||
| Desipramine (Norpramin) | ||
| Effexor (Affex) | 1.5 mg/ tablet | |
| Fexepth (Fexganex) | 5 mg/ tablet | |
| Generic (Atomoxetine) | 2.5 mg/ tablet |
Pregnancy and breastfeeding: There are no known effects of prazosin on human pregnancy.Reserve brand name:
Drug class: Selective serotonine receptor stimulation (SST).Drug class effect strength: SST 1 mg/ tablet (over 30 minutes) SST 5 mg/ tablet SST 10 mg/ tablet
Atomoxetine (Strattera) works by increasing the levels of norepinephrine and dopamine in the brain. This neurotransmitter modulates the balance of microRNA and other types of microRNAs that are involved in a patient's post-surgical recovery. By reducing the symptoms of sleep apnea and by improving cognitive function, Strattera helps to reduce the risk of acute and chronic malabsorption syndrome. Antimuscarinic effects include, but are not limited to, the following :improved quality of sleep (sleep disorder)Reduces the need to use food to maintain the levels of the medication in the patient's body.Drug class action: Inhibits anushnthe immune system to suppress allergic reactions. Improve mast cell counts and natural healing.Drug classes list
As with all medications, Atomoxetine (Strattera) may cause your urine to be more acidic or more enriched for sugar,� compared to that of the comparator. Also, your urine may be more acidic or enriched for sugar,� in some cases, but not in others. Also, your urine may be enriched for sugar in some cases, but not in others. enriched with magnesium oxide black (E171)
Strattera is a preferred medication for the treatment of MDD due to its ability to lower the incidence and severity of symptoms of MDD such as shortness of breath, coughing, and chest pain. It is also an effective option in the management of primary adenocarcinoma of the breast, making it an go to treatment algorithm for early detection and treatment of early breast cancer.
Patients are directed to the online Patient Support service (the "Services") that provides information on the drugs at "Generics.com.au". The "Contact Us" button is shown under the "Help" button in the left-hand tab of the "Manufacturer Information" bar in the medicine guide. Patients can also provide more information, such as their medical history, prescription, and non-prescription status, by clicking on the "Get Patients Prescription" button at the end of the medicine guide. The "Contact Us" button is removed in case of patients providing "No Prescription" information, which is a process that requires patients to provide a personal prescription from a physician. The "Contact Us" page is then taken away.
Strattera is used to treat attention-deficit hyperactivity disorder (ADHD) and to help improve focus, reduce impulsivity, and improve the overall quality of life for children and adults. Strattera has a milder side effect profile compared to other ADHD medications. However, the safety and efficacy of Strattera in children and adults have not been thoroughly studied. The most common adverse effects of Strattera in children and adolescents are drowsiness, drowsiness, weakness, difficulty in breathing, insomnia, gastrointestinal disturbances, fatigue, and drowsiness. Strattera can also cause more severe and potentially life-threatening reactions in patients with severe ADHD, such as seizures, seizures with rapid-onset muscle movement, and/or sudden death. In addition, Strattera may cause drowsiness, dizziness, drowsiness, and other symptoms associated with impaired judgment, concentration, and concentration-related tasks. Strattera may also cause other side effects, including decreased appetite, insomnia, dry mouth, and decreased libido. In some cases, Strattera may cause serious or life-threatening allergic reactions or anaphylaxis. Allergic reactions to Strattera are not known to occur in children and adolescents.
There are no standard dosage guidelines for children and adolescents. Generally, adults and adolescents receive the maximum recommended dose (12.5 mg to 80 mg daily) of Strattera. However, more specific dosage recommendations may be required based on the child’s medical condition and response to treatment. A dosage adjustment may be necessary in patients with a history of seizures or other neurological disorders. Children and adolescents taking Strattera are at a higher risk of developing side effects compared to adults and adolescents not taking the medication. The recommended dose of Strattera in children and adolescents is 40 mg per day, taken orally. However, a higher dose may be necessary for older children or those with certain medical conditions or who are taking a higher-than-recommended dosage. Children taking Strattera are at an increased risk for allergic reactions, such as anaphylaxis, and allergic-type reactions, such as hives, swelling, and breathing difficulty. In children and adolescents, Strattera may cause more serious side effects such as drowsiness, drowsiness, dizziness, drowsiness, confusion, and hyperactivity. The maximum recommended dose of Strattera in children and adolescents is 80 mg per day, taken orally. The maximum recommended dose of Strattera in adolescents is 40 mg per day, taken orally. A dosage adjustment is also needed in pediatric patients with renal impairment and seizures. In children and adolescents with a history of seizures, Strattera may cause an increase in the risk of suicidal thinking and behavior. Strattera is not recommended for use in children and adolescents younger than 12 years old without a medical diagnosis.
Strattera is contraindicated in the following patients:
Strattera may have serious or life-threatening side effects in adults. Serious side effects of Strattera in children and adolescents include:
Stade de France Pharmacy